RaySearch Laboratories AB (publ) (RAY B.ST) Osake Kurssi
RaySearch Laboratories AB (publ) Kurssi
Liikevaihto on kasvanut 16,9 % vuodessa viimeisten 19 vuoden aikana 1,34 Mrd. SEK:een. Osakekohtainen tulos on kasvanut 10,2 % vuodessa viimeisten 19 vuoden aikana. RaySearch Laboratories AB (publ)n nettomarginaali on nyt 16,9 %, noussut −7,4 %:sta muutama vuosi sitten. RaySearch Laboratories AB (publ)n osinkotuotto on tällä hetkellä noin 1,80 %. Jakosuhde on noin 45 % tuloksesta. Osinko on kasvanut 18,5 % vuodessa viimeisten 17 vuoden aikana. Analyytikoiden mediaanitavoitehinta on 336,60 SEK, eli yli nykyhintaa 101,9 %. 9 analyytikosta 8 suosittaa ostoa — kokonaiskonsensus on Osta.
RaySearch Laboratories AB (publ) osakekurssi
Hae nämä tiedot Eulerpool API:n kautta
100 000 pyyntöä/kk ilmaiseksi · ei luottokorttia
RaySearch Laboratories AB (publ) liiketoimintamalli ja osakeanalyysi
Usein kysytyt kysymykset RaySearch Laboratories AB (publ) -osakkeesta
The business model of RaySearch Laboratories AB (publ) is focused on developing innovative software solutions for radiation therapy. RaySearch provides advanced treatment planning system (TPS) software, known as RayStation, that is used by healthcare professionals to optimize cancer treatments. The company aims to improve personalized treatment accuracy while minimizing side effects and costs. RayStation integrates with various treatment delivery systems, ensuring compatibility with a wide range of radiotherapy machines. RaySearch also offers support services and training to help healthcare institutions effectively utilize their software. This business model allows RaySearch Laboratories AB (publ) to contribute to advancements in cancer treatment through cutting-edge technology.
RaySearch Laboratories AB (publ) is primarily active in the healthcare and medical technology industries.
The main competitors of RaySearch Laboratories AB (publ) in the market are Varian Medical Systems, Elekta, and Accuray Incorporated.
RaySearch Laboratories AB (publ) is a leading medical technology company based in Sweden. Established in 2000, RaySearch specializes in developing innovative software solutions for radiation therapy, including treatment planning systems and advanced algorithms. The company's products enable healthcare professionals to deliver precise and personalized cancer treatments, ultimately improving patient outcomes. RaySearch has a strong presence in the global market and collaborates with renowned research institutions and cancer centers worldwide. With a commitment to continuous innovation and expertise in radiation therapy, RaySearch Laboratories AB (publ) is dedicated to advancing cancer care through cutting-edge technology and industry-leading solutions.
RaySearch Laboratories AB (publ) has achieved several significant milestones. Firstly, the company has developed and commercialized advanced software solutions for radiation therapy planning, including the widely acclaimed RayStation®. They have continuously improved their product portfolio to meet the evolving needs of the industry. Secondly, RaySearch Laboratories AB (publ) has expanded its global footprint by establishing a strong presence in key markets worldwide. Thirdly, the company has fostered successful collaborations with leading cancer centers and research institutions, enhancing their technological advancements and clinical expertise. Lastly, RaySearch Laboratories AB (publ) has consistently delivered strong financial results, demonstrating its solid growth trajectory in the market.
RaySearch Laboratories AB (publ) is primarily present in various countries and regions around the world. Some of the key areas where the company has a strong presence include Sweden, the United States, Germany, the United Kingdom, France, China, Canada, and Japan. RaySearch Laboratories AB (publ) has established itself as a global player in the field of medical technology, specializing in advanced software solutions for radiation therapy. With its widespread presence and reach, the company continues to deliver innovative products and services to healthcare providers and professionals worldwide.
RaySearch Laboratories AB (publ) is a leading provider of innovative software solutions for radiation therapy. The company's values are centered around excellence, innovation, and patient care. With a strong corporate philosophy, RaySearch Labs is committed to continuously improving cancer treatment by developing cutting-edge technologies. They strive to empower healthcare professionals with advanced tools that optimize treatment planning and delivery, ultimately enhancing patient outcomes. RaySearch Labs' dedication to research and development ensures that they remain at the forefront of the radiation therapy industry, delivering high-quality solutions that address the evolving challenges in cancer treatment.
Analyytikot asettavat tällä hetkellä RaySearch Laboratories AB (publ)-osakkeelle keskimääräisen tavoitehinnan 336,60 SEK (mediaani: 336,60 SEK), mikä merkitsee +70,9 % viimeisimpään hintaan verrattuna. Konsensus perustuu 9 analyytikkoarvioon.
RaySearch Laboratories AB (publ) Analyytikkojen kursstavoitteet 2026
9 analyytikkoa arvioi tällä hetkellä RaySearch Laboratories AB (publ)-osaketta: 8 suosittaa ostoa, 1 pitoa ja 0 myyntiä. Vuodelle 2026 analyytikot odottavat RaySearch Laboratories AB (publ)-yhtiöltä 1,40 Mrd. SEK liikevaihtoa ja 6,91 SEK osakekohtaista tulosta.
RaySearch Laboratories AB (publ) Analyytikkojen kursstavoitteet 2026
Nykyisellä valuuttakurssilla RaySearch Laboratories AB (publ)-osake noteerataan hintaan 15,21 EUR (166,70 SEK).
RaySearch Laboratories AB (publ)-osake (RAY B.ST) on listattuna 9 pörssissä, muun muassa: NASDAQ (RSLBF), London (0GRZ.L), Frankfurt (27R.F), Düsseldorf (27R.DU), Berlin (27R.BE), Stockholm (RAY B.ST).
RaySearch Laboratories AB (publ) is a leading provider of innovative software solutions for radiation therapy planning and execution. The company operates three business areas: RayStation, RayCare, and RayIntelligence. RayStation offers a powerful software solution for radiation therapy planning. The software combines advanced technologies and clinical experience to ensure precise and effective treatment planning. RayStation provides a wide range of tools and functions for planning radiation therapy procedures, including IMRT, VMAT, and arc therapy, as well as various special techniques such as stereotactic body radiation therapy and proton therapy. RayCare provides a complete software solution for managing radiation therapy centers, including resource management, patient management, and treatment management. RayCare improves processes in radiation therapy through fast, efficient, and secure management of all tasks and workflows. RayIntelligence includes software solutions for data analysis and processing in radiation therapy. Using advanced technologies such as artificial intelligence and machine learning, RayIntelligence offers a platform for creating and visualizing data models and analyses to optimize radiation therapy. RaySearch Laboratories AB (publ) offers a wide range of products and services to ensure successful and effective radiation therapy. From planning and management to data analysis and optimization, the company provides innovative solutions and support. RaySearch Laboratories AB (publ)'s customers include hospitals, medical practices, and research institutions that want to offer high-quality and personalized radiation therapy. RaySearch Laboratories AB (publ) is pursuing a long-term growth plan to solidify its position as a worldwide leader in software solutions for radiation therapy. The company invests in research and development to continually offer innovative technologies and solutions. Additionally, the company expands its reach through partnerships and alliances with other companies and institutions worldwide. In conclusion, RaySearch Laboratories AB (publ) is an innovative and dynamic company specializing in the development and improvement of software solutions for radiation therapy. Through its three business areas and wide range of products and services, the company provides comprehensive solutions for successful and effective radiation therapy.
odotettu liikevaihto RaySearch Laboratories AB (publ) on 1,40 Mrd. SEK. Tämä luku perustuu nykyisiin talousarvoihin ja heijastaa yhtiön liiketoimintasuoritusta.
odotettu voitto RaySearch Laboratories AB (publ) on 237,05 M SEK. Nettovoitto kuvastaa yhtiön kannattavuutta kaikkien kulujen vähentämisen jälkeen.
RaySearch Laboratories AB (publ):n hinta-voitto-suhde (P/E) on tällä hetkellä 24,12. P/E-suhde vertaa nykyistä osakekurssia osakekohtaiseen tulokseen ja auttaa sijoittajia arvioimaan RaySearch Laboratories AB (publ)-osakkeen arvostusta.
RaySearch Laboratories AB (publ):n hinta-myynti-suhde (P/S) on tällä hetkellä 4,09. P/S-suhde vertaa markkina-arvoa vuosittaisiin tuloihin ja toimii RaySearch Laboratories AB (publ)-osakkeen arvostuskennuslukuna.
RaySearch Laboratories AB (publ):n Eulpool-laatuscore on 7/10.
RaySearch Laboratories AB (publ):n ISIN on SE0000135485. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.
RaySearch Laboratories AB (publ):n WKN on 905265. WKN (Wertpapierkennnummer) on kuusinumeroinen saksalainen arvopaperin tunnus.
RaySearch Laboratories AB (publ):n ticker on RAY B.ST. Tämä pörssinoteeraus käytetään RaySearch Laboratories AB (publ)-osakkeiden kauppaan pörssissä.
RaySearch Laboratories AB (publ) osake
RaySearch Laboratories AB (publ) vertaisryhmä
RaySearch Laboratories AB (publ) Ticker
RaySearch Laboratories AB (publ) FIGI
Kaikki tunnusluvut ja syvällinen analyysi RaySearch Laboratories AB (publ):sta
Meidän osakeanalyysimme RaySearch Laboratories AB (publ)-osakkeesta sisältää tärkeitä taloudellisia tunnuslukuja, kuten liikevaihdon, voiton, P/E-luvun, P/S-luvun, EBIT:n sekä tietoja osingosta. Lisäksi tarkastelemme asioita kuten osakkeet, markkina-arvo, velat, oma pääoma ja vastuut RaySearch Laboratories AB (publ):n yhteydessä. Jos etsit yksityiskohtaisempaa tietoa näistä aiheista, tarjoamme alisivuillamme kattavia analyysejä: